The Combination of Immune Checkpoint Blockade and Angiogenesis Inhibitors in the Treatment of Advanced Non-Small Cell Lung Cancer
Sijia Ren(Zhejiang University), Penghui Zhou(Sun Yat-sen University)
Cited by 100
Related Papers
Stress–glucocorticoid–TSC22D3 axis compromises therapy-induced antitumor immunity
|Nature Medicine|2019|367
Cannabis suppresses antitumor immunity by inhibiting JAK/STAT signaling in T cells through CNR2
|Signal Transduction and Targeted Therapy|2022|79
Carfilzomib modulates tumor microenvironment to potentiate immune checkpoint therapy for cancer
|EMBO Molecular Medicine|2021|56
The hapten rigidity improves antibody performances in immunoassay for rifamycins: Immunovalidation and molecular mechanism
|Journal of Hazardous Materials|2024|45
Loss of function of BRCA1 promotes EMT in mammary tumors through activation of TGFβR2 signaling pathway
|Cell Death and Disease|2022|24